At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 24 enrolled
Drug / intervention
Testosterone +1 moredrug
Likely dose
Testosterone 200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Double Blind, Placebo Controlled, Parallel Pilot Study to Test the Effect of Testosterone Treatment on Peripheral Vascular Disease in Hypogonadal Men With Type 2 Diabetes Mellitus
In Brief
A Phase 4 clinical trial evaluating Testosterone and saline for Hypogonadism and 2 related conditions. Completed, enrolled 24 participants across 1 site.
Detailed Summary
There is increasing evidence of the linkage of type 2 diabetes with low testosterone levels in men.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypogonadism, Peripheral Vascular Disease, Type 2 Diabetes
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2006
First PostedJul 2007
Primary CompletionDec 2009
TodayJul 2026
First PostedJul 20, 2007
Enrollment StartFeb 1, 2006
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 18.9 years ago
Interventions
Testosteronedrug
Sustanon- 200mg- Intramuscular testosterone every 2 weeks
salinedrug
Saline injection every two weeks